RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma

Annals of Clinical and Laboratory Science

Volumn 43, Issue 2, 2013, Pages 135-144

  Zeng, Xian Cheng ^a   Zhang, Tong ^a   Huang, De Hao ^b   Wang, Guo Ying ^a   Chen, Wei ^c   Li, Hua ^a   Zhang, Jian ^a   Fang, Tian Ling ^d   Zhang, Qi ^a,e   Chen, Gui Hua ^a,e  

^a SUN YAT SEN UNIVERSITY   (China)

^b The First Peoples Hospital of Foshan   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e Guangdong Provincial Key Laboratory of Liver Disease Research   (China)

Author keywords

Hepatocellular carcinoma; HLA G; Immune surveillance; NK cytotoxicity; RNA Interfering

Indexed keywords

ANTIBIOTIC G 418; HLA G ANTIGEN; MESSENGER RNA; SMALL INTERFERING RNA;

ANTIGEN EXPRESSION; ARTICLE; CYTOLYSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOSURVEILLANCE; LIVER CELL CARCINOMA; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEADY STATE; WESTERN BLOTTING;

HEPATOCELLULAR CARCINOMA; HLA-G; IMMUNE SURVEILLANCE; NK CYTOTOXICITY; RNA INTERFERING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA PRIMERS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE KNOCKDOWN TECHNIQUES; HLA-G ANTIGENS; HUMANS; IMMUNOLOGIC SURVEILLANCE; KILLER CELLS, NATURAL; LIVER NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84878191265     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye QH, Wang L, Zhou J, Qiu SJ, Li Y, Ji XN, Liu H, Xia JL, Wu ZQ, Fan J, Ma ZC, Zhou XD, Lin ZY, Liu KD. A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;30: 187-196.
3. Singer G, Kurman RJ, McMaster MT, Shih IeM. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 2002;26: 914-920.
4. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 2005;65: 10139-10144.
5. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000;355: 2138.
6. Khosrotehrani K, Le Danff C, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S. HLA-G expression in atopic dermatitis. J Invest Dermatol 2001;117: 750-752.
7. Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, Dubertret L, Carosella ED. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?. Am J Pathol 2001; 159: 71-77.
8. Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005;79: 15226-15237.
9. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol 2008;29: 313-321.
10. Sheu J, Shih Ie M. HLA-G and immune evasion in cancer cells. J Formos Med Assoc 2010;109: 248-257.
11. Rouas-Freiss N, Gonçalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997;94: 11520-11525.
12. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N, Carosella ED. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999;43: 203-211.
13. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigenspecific CTL cytolysis. J Immunol 2001;166: 5018-5026.
14. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001;13: 385-394.
15. Urosevic M, Dummer R. Human leukocyte antigen-G and cancer immune- editing. Cancer Res 2008; 68: 627-630.
16. Sun LL, Han Y, Chen JH, Yao YQ. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro. Fertil Steril 2008;90: 2398-2405.
17. Yie SM, Yang H, Ye SR, et al. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007;14: 2721-2729.
18. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. HLA-G expression in gastric cancer. Anticancer Res 2006;26: 2467-2472.
19. Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007;20: 375-383.
20. Hansel DE, Rahman A, Wilentz RE, Shih IeM, McMaster MT, Yeo CJ, Maitra A. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. Int J Gastrointest Cancer 2005;35: 15-23.
21. Tripathi P, Agrawal S. Non-classical HLA-G antigen and its role in the cancer progression. Cancer Invest 2006;24: 178-186.
22. Shih Ie M. Application of human leukocyte antigen-G expression in the diagnosis of human cancer. Hum Immunol 2007;68: 272-276.
23. Li BL, Lin A, Zhang XJ, Zhang X, Zhang JG, Wang Q, Zhou WJ, Chen HX, Wang TJ, Yan WH. Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 2009;74: 213-221.
24. Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009;15: 4686-4693.
25. Menier C, Riteau B, Carosella ED, Rouas-Freiss N. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Int J Cancer 2002;100: 63-70.
26. Navarro F, Llano M, Bellón T, Colonna M, Geraghty DE, López-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999;29: 277-83.
27. Adrián Cabestré F, Moreau P, Riteau B, Ibrahim EC, Le Danff C, Dausset J, Rouas-Freiss N, Carosella ED, Paul P. HLA-G expression in human melanoma cells: protection from NK cytolysis. J Reprod Immunol 1999;43: 183- 193.
28. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J.2005;19: 662-664.
29. Braud VM, Allan DS, O'Callaghan CA, oS̈derström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391: 795-799.
30. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006;4: e9.
31. LeMaoult J, Caumartin J, Carosella ED. Exchanges of membrane patches (trogocytosis) split theoretical and actual functions of immune cells. Hum Immunol 2007;68: 240-243.
32. Zidi I, Guillard C, Carosella ED, Moreau P. Soluble HLA-G induces NF-kappaB activation in natural killer cells. J Physiol Biochem 2010;66: 39-46.
33. Yao AY, Tang HY, Wang Y, Feng MF, Zhou RL. Inhibition of the activating signals in NK92 cells by recombinant GSTsHLA- G1a chain. Cell Res 2004;14: 155-160.
34. Yu Y, Wang Y, Feng M. Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse. Hum Immunol 2008;69: 16-23.
35. Chen A, Shen Y, Xia M, Xu L, Pan N, Yin Y, Miao F, Shen C, Xie W, Zhang J. Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2010;10: 158-163.
36. Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clinical Cancer Research 2009;15: 4686-4693.
37. Lin A, Chen HX, Zhu CC, Zhang X, Xu HH, Zhang JG, Wang Q, Zhou WJ, Yan WH. Aberrant human leucocyte antigen- G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med 2010;14: 2162-2171.